Despite the availability of convenient, noninvasive screening tests such as Fecal
Immunochemical Test (FIT) and multi-target stool DNA test (MtSDNA or Cologuard), only …

The goal of the American Cancer Society (ACS) 2018 guideline update for colorectal cancer
(CRC) screening is to reduce the incidence of and deaths from CRC for average-risk adults …

PURPOSE We wanted to better understand patient preferences and decision making about
options for colorectal cancer screening. Consistency in patient preferences could improve …

Background Colorectal cancer screening guidelines in the United States recommend that
decisions about screening should incorporate patient preferences, but little is known about …

OBJECTIVE: To measure patient preferences for four different screening strategies: annual
fecal occult blood testing (FOBT) alone; flexible sigmoidoscopy (FSIG) every 5 years alone; …

Primary care physicians have been urged to match colorectal cancer screening to the
circumstances and preferences of each individual patient. Elements of personalized …

Background. Eliciting patient preferences within the context of shared decision making has
been advocated for colorectal cancer (CRC) screening, yet providers often fail to comply …

BACKGROUND: The purpose of this study was to identify factors associated with colorectal
cancer (CRC) screening test preference and examine the association between test …

Objective: To assess patient preferences for 1 of the recommended colorectal cancer
screening options or stool DNA testing (sDNA), a novel noninvasive screening test. Study …

BACKGROUND Despite the availability of multiple effective screening tests for colorectal
cancer, screening rates remain suboptimal. The literature documents patient preferences for …